Geniposide suppressed OX-LDL-induced osteoblast apoptosis by regulating the NRF2/NF-?B signaling pathway

Background Osteoporosis (OP), due to microarchitectural alterations, is associated with decreased bone mass, declined strength, and increased fracture risk. Increased osteoblast apoptosis contributes to the progression of OP. Natural compounds from herbs provide a rich resource for drug screening. Our previous investigation showed that geniposide (GEN), an effective compound from Eucommia ulmoides, could protect against the pathological development of OP induced by cholesterol accumulation. Methods The rat OP models were duplicated. Dual- energy X-ray absorptiometry, hematoxylin and eosin staining, and immunohistochemistry were used to evaluate bone changes. TUNEL/DAPI staining assays were used for cell apoptosis detection. Protein expression was determined by western blotting assays. Results A high-fat diet promoted OP development in vivo, and OX-LDL stimulated osteoblast apoptosis in vitro. GEN exhibited protective activities against OX-LDL-induced osteoblast apoptosis by increasing the NRF2 pathway and decreasing the NF-kappa B pathway. PDTC, an NF-kappa B inhibitor, could further promote the biological functions of GEN. In contrast, ML385, an NRF2 inhibitor, might eliminate GEN's protection. Conclusion GEN suppressed OX-LDL-induced osteoblast apoptosis by regulating the NRF2/NF-kappa B signaling pathway.

Automated summary

In this study, geniposide, an active compound from Eucommia ulmoides, was found to protect against osteoblast apoptosis induced by oxidized low-density lipoproteins (OX-LDL) by regulating the NRF2/NF-kappa B signaling pathway, thereby preserving bone health.